Last reviewed · How we verify

NCT06949787

To Compare Sweeping of Membranes Versus Expectant Management for Spontaneous Onset of Labor and Vaginal Delivery.

Not yet recruiting NA Last updated 29 April 2025
What this trial tests

NA trial testing Membrane sweeping in Post-Term Pregnancy in 132 participants. Not yet recruiting.

Timeline
1 May 2025
Primary endpoint
31 October 2025
31 October 2025

Quick facts

Lead sponsorMuhammad Aamir Latif
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment132
Start date1 May 2025
Primary completion31 October 2025
Estimated completion31 October 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Muhammad Aamir Latif — full company profile →

Who can join

Adults 18 to 40, female only, with Post-Term Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is planned to fill the gaps regarding the effectiveness of sweeping of membranes versus expectant management in terms of spontaneous onset of labor and vaginal delivery in post-date primigravida.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Membrane sweeping

Trials testing the same drug.

Other Muhammad Aamir Latif trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06949787.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing